Mesoblast Limited (MESO)
NASDAQ: MESO · Real-Time Price · USD
8.34
-0.14 (-1.65%)
At close: Nov 4, 2024, 4:00 PM
8.20
-0.14 (-1.68%)
After-hours: Nov 4, 2024, 7:33 PM EST

Mesoblast Statistics

Total Valuation

Mesoblast has a market cap or net worth of $967.28 million. The enterprise value is $1.02 billion.

Market Cap 967.28M
Enterprise Value 1.02B

Important Dates

The last earnings date was Wednesday, August 28, 2024, after market close.

Earnings Date Aug 28, 2024
Ex-Dividend Date n/a

Share Statistics

Mesoblast has 1.14 billion shares outstanding. The number of shares has increased by 26.87% in one year.

Current Share Class n/a
Shares Outstanding 1.14B
Shares Change (YoY) +26.87%
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 851.65M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS 12.02
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 173.26
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.18, with a Debt / Equity ratio of 0.25.

Current Ratio 1.18
Quick Ratio 1.14
Debt / Equity 0.25
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -2.81

Financial Efficiency

Return on equity (ROE) is -17.91% and return on invested capital (ROIC) is -5.95%.

Return on Equity (ROE) -17.91%
Return on Assets (ROA) -5.41%
Return on Capital (ROIC) -5.95%
Revenue Per Employee $80,849
Profits Per Employee -$1.20M
Employee Count 73
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

Income Tax -191,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +223.26% in the last 52 weeks. The beta is 2.38, so Mesoblast's price volatility has been higher than the market average.

Beta (5Y) 2.38
52-Week Price Change +223.26%
50-Day Moving Average 7.95
200-Day Moving Average 6.01
Relative Strength Index (RSI) 44.85
Average Volume (20 Days) 159,511

Short Selling Information

Short Interest 1.25M
Short Previous Month 931,139
Short % of Shares Out 1.42%
Short % of Float n/a
Short Ratio (days to cover) 6.38

Income Statement

In the last 12 months, Mesoblast had revenue of $5.90 million and -$87.96 million in losses. Loss per share was -$0.09.

Revenue 5.90M
Gross Profit -35.17M
Operating Income -57.97M
Pretax Income -73.25M
Net Income -87.96M
EBITDA -56.08M
EBIT -57.97M
Loss Per Share -$0.09
Full Income Statement

Balance Sheet

The company has $62.96 million in cash and $118.92 million in debt, giving a net cash position of -$55.96 million or -$0.05 per share.

Cash & Cash Equivalents 62.96M
Total Debt 118.92M
Net Cash -55.96M
Net Cash Per Share -$0.05
Equity (Book Value) 480.36M
Book Value Per Share 0.42
Working Capital 13.22M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$48.46 million and capital expenditures -$271,000, giving a free cash flow of -$48.73 million.

Operating Cash Flow -48.46M
Capital Expenditures -271,000
Free Cash Flow -48.73M
FCF Per Share -$0.04
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -982.24%
Pretax Margin -1,493.51%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin -818.02%

Dividends & Yields

Mesoblast does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -26.87%
Shareholder Yield -26.87%
Earnings Yield -9.09%
FCF Yield -5.04%

Analyst Forecast

The average price target for Mesoblast is $11.50, which is 37.89% higher than the current price. The consensus rating is "Strong Buy".

Price Target $11.50
Price Target Difference 37.89%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) 168.66%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on January 10, 2024. It was a reverse split with a ratio of 0.5:1.

Last Split Date Jan 10, 2024
Split Type Reverse
Split Ratio 0.5:1

Scores

Mesoblast has an Altman Z-Score of -0.92 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -0.92
Piotroski F-Score 3